PetMeds® Press Releases

Call Us: 1-800-738-6337

09.01.2022

PetMeds® Will Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Delray Beach, Florida, September 01, 2022 – PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health Expert®, announces its participation in the Morgan Stanley 20th Annual Global Healthcare Conference, scheduled for Sept. 12-14 at the Sheraton New York Hotel in New York.

PetMed Express President and CEO Matt Hulett and CFO Christine Chambers will represent the company in a fireside chat scheduled for 2:55 p.m. (Eastern Time) on Wednesday, Sept. 14.

PetMeds® will join more than 200 leading public and private companies at this year’s Morgan Stanley Global Healthcare Conference, along with investors, portfolio managers, chief investment officers, analysts and other attendees. For more information on the Conference, click here: https://msevents.dealogic.com/clientportal/Conferences/Custom/List/229?menuItemId=102

About PetMeds®
Founded in 1996, Petmeds.com is Your Trusted Pet Health Expert providing fast, easy and helpful service to over ten million customers across the U.S. by delivering prescription and non-prescription medications and pet supplies for less, direct to the consumer through its PetMeds® toll-free number, on the Internet through its website Petmeds.com, or with the PetMeds® mobile app available for free at Google Play for Android and the App Store for iOS.

FORWARD LOOKING STATEMENTS
The statements contained in this press release that are not purely historical are forward-looking statements, including statements regarding PetMeds’ expectations, beliefs, intentions or strategies regarding the future. All forward-looking statements included in this press release are based upon information available to PetMeds as of the date hereof, and PetMeds assumes no obligation to update any such forward-looking statements. Forward-looking statements involve risks and uncertainties, which could cause actual results to differ materially from those projected. These and other risks relating to PetMed’ business are set forth inPetMeds’ Form 10-K for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission.